We ruled the best sellers you launch next to: 76% fail at least one rule. Use the wording the clean ones use, while every claim is still unpublished and changing it costs a text edit, not a takedown or a reprint.
Copy goes live in a fixed sequence: label, listing, ads, then site and emails. Each answers to a different rulebook. Our stage-by-stage guide sets out what to clear at each stage, and which one is expensive to change.
All four checked before they go out.
More than 3 products or listings? The full audit covers up to 10 products, and anything larger we price in writing before we start. Prices in USD.
phrase checks run by our engine, and it keeps scanning
of top listings checked carry a finding that fails an FDA, FTC or marketplace standard
the most per violation a brand on FTC penalty notice can be exposed to
The FDA pre-approves none of the supplement products on the US market. Amazon’s Restricted Products policy applies from the day a listing goes live, and a listing can be suppressed without notice. The risk is locked in the day the copy is written, so Launch Clean rules it against the same FDA, FTC and marketplace standards first, with Health Canada if you launch in Canada.
Launch once
In the draft, a claim costs a text edit to change. Every line is ruled in minutes, each one that fails comes back at the strongest wording the rules allow with the benefit still in it, and a licensed pharmacist signs the file in five business days. The first version you publish is the one written to keep selling.
Label at the printer, listing in draft, first ads written.
Against 109 published standards. What fails is reworded to the strongest the rules allow.
A licensed pharmacist signs the file before a shopper or an ad reviewer reads a word.
The listing, the first ads and the label go out on wording already ruled, saying the most the rules allow.
The other wayLive→Flagged→Reworded→Relaunchedwith the launch budget spent in between.
A draft takes a text edit to change. Live copy puts history, standing or a reprint at stake.
A takedown in month two leaves an enforcement record on a listing and seller profile with nothing behind them. Your search rank never had time to build, and the days offline eat the budget meant to buy momentum.
Google’s strikes apply to the ad account, not just the ad, and an account on hold cannot run any ads. A new one has nothing to fall back on, so the first ad set is worth more attention than its budget suggests.
Carton copy is the most expensive place to fix a claim. Reviewing it before the print run adds nothing to the fee. Reprinting ten thousand cartons after a warning letter is its own line item.
A new brand has no history to absorb a week offline, and the opening budget is spent in exactly that week. The failing sentence costs you more than it costs an established seller, and before launch it can still be changed in the draft.
Launch with the claims removed that can suppress a listing in week two, hold a payout, or restrict an ad account with the budget already committed. Keep the strongest wording the rules allow.
Every line read against all 109 published Claims Verified standards, drawn from FDA and FTC rules, Health Canada and marketplace policy.
Title, bullets, description and the hidden search keywords shoppers never see, checked before the listing ever meets a marketplace policy check.
What your product says it does, where the FDA disclaimer sits, and the claims your co-packer’s template quietly carries. Launching in Canada too: once your licence (NPN) is issued, your copy is checked against the purpose Health Canada approved for it, before a word is printed.
Caught before the print run, the fix is a text edit. Caught after, it is a reprint.
Product pages and launch emails read before anyone buys, and before class-action law firms archive them.
Launch ad copy ruled against Meta and Google health-ads rules while the account history is still spotless.
A pharmacist-signed go / no-go ruling on each claim, a rewrite at the strongest wording the standard allows for everything flagged, your FDA structure/function notice drafted for you to sign and file within 30 days of first marketing, and one file that answers Amazon onboarding, ad-platform review and payment-provider checks.
One signed PDF, with a verification code, that answers who reviewed your claims, against what, and when.
A month of claims monitoring is included: we re-scan your live copy after launch and flag anything that drifts from what was signed. In that month the Watch agent finds changed copy every week, drafts the fix and waits for your decision.
Pass the screen and you qualify for the Mark, our seal, licensed only to brands that pass. The licence is confirmed in writing the day you pass, and your seal, public verification page and entry on the verified register go live then too.
Your entry on the register is live the day your licence is issued.
Every supplement launch publishes the same four things, the label, the listing, the first ads and the emails, in almost the same order, and each one answers to a different set of rules. Get them in the wrong order and you pay for the same sentence twice: once at the printer and once in a relist. This is the order we work in, what governs each stage, and the mistake that shows up most often at each one.
Answers to: FDA structure/function and disease claim rules, and in Canada your Health Canada licence, which states the recommended use that is actually authorised.
The trap: a claim that is fine in an ad becomes a labelling claim on a carton, and a Canadian licence authorises one specific use while the label promises three. Marketing beyond the authorised use is not common in what we have scanned, roughly one brand in thirty, but it is invisible from the US side and checkable against the licence itself. Catch it here and it costs an edit. Catch it later and the cartons are already printed.
Clear before printing: the front panel, every claim on the back, the disclaimer placement, and the product name itself. A name that implies treatment is a claim, and renaming after a print run is the most expensive fix in this business.
Answers to: the marketplace policy that governs the listing, plus the same FDA and FTC rules. On Amazon that is the supplements policy, which prohibits disease claims and disease terms in backend keywords, plus the Supplement Facts panel match, where every milligram figure in your title, bullets, description and images has to agree with the panel.
The trap: backend keywords. They are invisible to a shopper, they feel like SEO rather than copy, and they are read as claims. The second trap is the mismatch between a rounded number in a bullet and the exact figure on the panel.
Clear before publishing: title, all bullets, description, A+ content (the images and text below the bullets), backend keywords, and every image containing text.
Answers to: Meta's advertising standards for health, and Google's healthcare and medicines policy. Meta's standards cover implied before-and-after results, sensational health language and personal-attribute framing, which is the "Struggling with [condition]?" construction.
The trap, and this is the one nobody is told: under Google's strike system, strikes apply to the ad account, not to the ad, and an account on hold cannot run any ads. A new account has no history to fall back on. This is why stage three is worth more attention than its budget suggests, and why "we will fix it if it becomes a problem" is not a plan.
Clear before running: every creative variant, the primary text, headlines, and any landing page the ad points to.
Answers to: the FTC substantiation standard, which asks for evidence you hold before the claim runs rather than after, and in Canada the Competition Act, where the proof of an adequate and proper test lies on the person making the representation.
The trap: welcome flows and abandoned-cart sequences get written once, by whoever is fastest, and then run untouched for years. They are the least reviewed copy a brand owns and the most repeated.
Clear before sending: the welcome sequence, the product education emails, and anything on your own site that a retail buyer or an acquirer will read later.
Launch Clean includes the first month of monitoring for both. After that it is from $350 a month, and a brand that does not take it should treat its report as a record of one date, not a standing clearance.
Upload your drafts and each one is ruled in your dashboard: what must change before launch, the rewrite, and the passing wording collected in one place.
A simplified preview. Ask about any new line and the rewrite is re-checked against the same standards.
$950 starts the five-day clock.
If what arrives is not the document the public sample report shows, it is refunded in full. See the sample report.
A price that went up when we found more would give us a reason to find more.
Nobody can buy a document dated last month. A review from February is the difference between having checked and saying you meant to. Every signed file carries its date, and anyone can hash the file and confirm that date on our site.
If a platform flags a line the pharmacist signed, we fix it and back your appeal, free, for 12 months after the file is signed. The limits in our terms apply. If you pass and license the mark, what you may say is marketing claims reviewed by a licensed pharmacist, never “pharmacist approved”: the reviewer read your wording, not your product.
Launch once, on copy that says the most the rules allow. For brands between formulation and first sale: label at the printer, Shopify store in draft, Amazon listing unpublished. Email audit@claimsverified.org with your brand name and SKU count, or send the request form, with Launch Clean already chosen. We ask for your target launch date when we confirm scope. We confirm scope within one business day, and drafts are reviewed on the same five-business-day clock as the full audit.
Review of marketing language only, not product testing, formulation, facility compliance, or legal advice. Findings are our opinion under the published Claims Verified standards.
The independent standard for supplement and telehealth claims. Our AI rules a brand’s public supplement claims against 109 published standards. Each failing line is rewritten to the rules. A licensed pharmacist signs every Claims Review Report.